Lakefront Biotherapeutics

As of March 31, 2026, Lakefront Biotherapeutics has 65.90M shares outstanding.

As of March 31, 2026, Lakefront Biotherapeutics trades at a trailing price-to-earnings ratio of 3.53. The price-to-sales ratio is 1.65, and the price-to-book ratio stands at 3.30.

As of March 31, 2026, Lakefront Biotherapeutics maintains a current ratio of 30.48, meaning it holds 30.5x the short-term assets needed to cover near-term liabilities.

Over the twelve months ended March 31, 2026, Lakefront Biotherapeutics posted a return on equity (ROE) of 182.59, showing how much profit the company earns on every dollar of shareholder capital. Return on assets (ROA) stands at 13.22, measuring how efficiently the asset base is converted into earnings. Return on capital employed (ROCE) is 270.87, useful for judging operating efficiency across full business cycles. Inventory turnover of 0.74 indicates how many times Lakefront Biotherapeutics sells and replaces its inventory over a year, a key working capital efficiency ratio.

These figures cover the twelve months ended March 31, 2026. That works out to an effective tax rate of 0.59, which can sit above or below the statutory corporate tax rate depending on foreign earnings mix, tax credits, and one-off items.

Over the twelve months ended March 31, 2026, Lakefront Biotherapeutics posted a gross margin of 98.01, reflecting its pricing power and cost economics. The operating margin of 57.14 and net profit margin of 46.83 provide insight into operational efficiency.

These figures cover the twelve months ended March 31, 2026. Free cash flow yield is negative at -16.98: the business is consuming cash rather than generating it, so any dividend is not covered by free cash flow. Total shareholder yield reaches 0.16, combining dividends paid with share buybacks and debt reduction for a fuller picture of capital returned to Lakefront Biotherapeutics shareholders.

As of March 31, 2026, Lakefront Biotherapeutics has an Altman Z-Score of 10.73, well above the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.